Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

US Patent 9675649 · Granted Jun 13, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligosaccharide as therapeutic agent for alcohol associated liver disease2024
Methods and therapies for treating atherosclerosis and/or hyperlipidemia using o2022
Method for production of a supporting member and a ladder frame or box frame2021
Semi-finished product, method for producing a semi-finished product and use ther2019
Chemoenzymatic synthesis of heparin and heparan sulfate analogs2018
Chemoenzymatic synthesis of heparin and heparan sulfate analogs2016
Gangliosides with a modified acyl function2010